Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Gov't & Regulatory

China Adds 70 Drugs to Insurance Reimbursement List; Negotiates 61% Average Price Cuts
Changsheng Bio Delisted following Major Vaccine Scandal
China Passes Comprehensive New Drug Administrative Law
China Allows Importation of "Small" Amounts of Non-China-Approved Drugs
China Adds 148 New Drugs to Basic Insurance List
ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China